Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Ganglioglioma in a Survivor of Infantile Glioblastoma.

Scheuermann A, Belongia M, Lawlor MW, Suchi M, Kaufman B, Vasudevaraja V, Serrano J, Snuderl M, Knipstein J.

J Pediatr Hematol Oncol. 2019 Jan 22. doi: 10.1097/MPH.0000000000001417. [Epub ahead of print]

PMID:
30676438
2.

Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.

Bader A, Heran M, Dunham C, Steinbok P.

J Neurosurg Pediatr. 2015 Aug;16(2):119-25. doi: 10.3171/2014.10.PEDS13634. Epub 2015 May 8. Review.

PMID:
25955808
3.

Malignant transformation of a desmoplastic infantile ganglioglioma in an infant carrier of a nonsynonymous TP53 mutation.

Prakash V, Batanian JR, Guzman MA, Duncavage EJ, Geller TJ.

Pediatr Neurol. 2014 Jul;51(1):138-43. doi: 10.1016/j.pediatrneurol.2014.02.012. Epub 2014 Feb 22.

PMID:
24768217
4.

[Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].

Naydenov E, Tzekov C, Minkin K, Nachev S, Marinov M.

Khirurgiia (Sofiia). 2009;(2-3):69-74. Bulgarian.

PMID:
20506796
5.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
6.

Congenital Glioblastoma Multiforme: An Unusual and Challenging Tumor.

Anestis DM, Tsitsopoulos PP, Ble CA, Tsitouras V, Tsonidis CA.

Neuropediatrics. 2017 Dec;48(6):403-412. doi: 10.1055/s-0037-1601858. Epub 2017 Apr 11. Review.

PMID:
28399590
7.

Case Report of Spontaneous Resolution of a Congenital Glioblastoma.

Davis T, Doyle H, Tobias V, Ellison DW, Ziegler DS.

Pediatrics. 2016 Apr;137(4). pii: e20151241. doi: 10.1542/peds.2015-1241. Epub 2016 Mar 15.

8.

Congenital Glioblastoma with Distinct Clinical and Molecular Characteristics: Case Reports and a Literature Review.

Kameda M, Otani Y, Ichikawa T, Shimada A, Ichimura K, Date I.

World Neurosurg. 2017 May;101:817.e5-817.e14. doi: 10.1016/j.wneu.2017.02.026. Epub 2017 Feb 16. Review.

PMID:
28214639
9.

Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report.

Hayashi Y, Iwato M, Hasegawa M, Tachibana O, von Deimling A, Yamashita J.

J Neurosurg. 2001 Jul;95(1):138-42.

PMID:
11453385
10.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
11.

Subventricular zone-associated glioblastoma: A call for translational research to guide clinical decision making.

Smith AW, Parashar B, Wernicke AG.

Neurogenesis (Austin). 2016 Aug 19;3(1):e1225548. eCollection 2016.

12.

First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.

Schijns VE, Pretto C, Devillers L, Pierre D, Hofman FM, Chen TC, Mespouille P, Hantos P, Glorieux P, Bota DA, Stathopoulos A.

Vaccine. 2015 May 28;33(23):2690-6. doi: 10.1016/j.vaccine.2015.03.095. Epub 2015 Apr 10.

13.

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

Flynn JR, Wang L, Gillespie DL, Stoddard GJ, Reid JK, Owens J, Ellsworth GB, Salzman KL, Kinney AY, Jensen RL.

Cancer. 2008 Sep 1;113(5):1032-42. doi: 10.1002/cncr.23678.

14.

Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.

Lukács G, Tóth Z, Sipos D, Csima M, Hadjiev J, Bajzik G, Cselik Z, Semjén D, Repa I, Kovács Á.

Ideggyogy Sz. 2018 Mar 30;71(3-04):95-103. doi: 10.18071/isz.71.0095.

PMID:
29889468
15.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

16.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
17.

Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.

Zhang G, Huang S, Zhang J, Wu Z, Lin S, Wang Y.

J Neurooncol. 2016 Apr;127(2):355-62. doi: 10.1007/s11060-015-2046-0. Epub 2016 Jan 2.

PMID:
26725096
18.

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr.

Neurosurgery. 2000 May;46(5):1123-8; discussion 1128-30.

PMID:
10807244
19.

Congenital glioblastoma multiforme: case report and review of the literature.

Hou LC, Bababeygy SR, Sarkissian V, Fisher PG, Vogel H, Barnes P, Huhn SL.

Pediatr Neurosurg. 2008;44(4):304-12. doi: 10.1159/000134922. Epub 2008 May 27. Review.

PMID:
18504417
20.

Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A review.

Bianchi F, Tamburrini G, Massimi L, Caldarelli M.

Childs Nerv Syst. 2016 Oct;32(10):1833-8. doi: 10.1007/s00381-016-3149-4. Epub 2016 Sep 20. Review.

PMID:
27659826

Supplemental Content

Support Center